Wnt-Signaling-Mediated Antiosteoporotic Activity of Porcine Placenta Hydrolysates in Ovariectomized Rats

Table 3

Serum and urinary Ca and P levels at the end of the 12-week treatment.

	OVX-control	OVX-WPPH	OVX-NPPH	OVX-EST	Sham-control
	(𝑛=10)	(𝑛=10)	(𝑛=10)	(𝑛=10)	(𝑛=10)
Serum calcium; (mg/dL)	10.9 ± 1.3	10.6 ± 1.4	10.2 ± 1.1	10.1 ± 1.2	10.1 ± 1.3
Serum phosphorus; (mg/dL)	8.18 ± 1.02^a	7.65 ± 0.92^ab	7.07 ± 0.91^b	6.97 ± 0.93^b*	6.94 ± 1.12^†
Urinary calcium; (mg/g creatinine)	1.32 ± 0.27^a	1.12 ± 0.21^b	0.91 ± 0.18^c	0.81 ± 0.16^c*	0.86 ± 0.14^†
Urinary phosphorus; (mg/g creatinine)	3.87 ± 0.71^a	3.18 ± 0.64^ab	2.84 ± 0.45^c	2.62 ± 0.46^c*	2.25 ± 0.38^†

Values are mean ± SD. *Significantly different among the different treatments in OVX rats at P < 0.05. ^a,b,cValues with different superscripts were significantly different among the OVX groups by Tukey’s test at P < 0.05. ^†Significantly different between OVX-control and Sham-control at P < 0.05.